Navigation
Inhalt
Over the last few years, biotechnology has developed into an important innovation and business sector for Germany. With its first-class scientific landscape, numerous internationally successful SMEs and a strong, globally active chemical and pharmaceutical industry, NRW is a major contributor to this development. One example of the state's leading international position in biotechnology is the fact that it occupies ninth place worldwide and first place – by a long way – in Europe in terms of the number of biotech patent applications.
Some 340 life science firms, of which approx. 200 specialize in biotechnology, mark the state as one of Europe's leading innovation centers. Major international players based in NRW include Miltenyi Biotec and Qiagen as well as many dynamically growing companies such as AiCuris, Cevec Pharmaceuticals, Evocatal or Protagen. Together, the core biotechnology companies – 71 in total – account for 42 percent of all German sales in this segment.
weiterführende/zusätzliche Infos
